Meeder Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.3M | Buy |
79,562
+9,584
| +14% | +$2.13M | 0.99% | 22 |
|
|
2025
Q4 | $16M | Buy |
69,978
+15,487
| +28% | +$3.53M | 0.86% | 24 |
|
|
2025
Q3 | $12.6M | Sell |
54,491
-25,040
| -31% | -$5.1M | 0.72% | 38 |
|
|
2025
Q2 | $14.8M | Buy |
79,531
+28,584
| +56% | +$5.31M | 0.91% | 23 |
|
|
2025
Q1 | $10.7M | Buy |
50,947
+39,576
| +348% | +$7.69M | 0.72% | 31 |
|
|
2024
Q4 | $2.02M | Sell |
11,371
-170,839
| -94% | -$31.4M | 0.14% | 81 |
|
|
2024
Q3 | $36M | Buy |
182,210
+69,593
| +62% | +$13M | 2.4% | 10 |
|
|
2024
Q2 | $19.3M | Buy |
112,617
+85,928
| +322% | +$14.2M | 1.35% | 19 |
|
|
2024
Q1 | $4.86M | Sell |
26,689
-115,815
| -81% | -$20M | 0.31% | 75 |
|
|
2023
Q4 | $22.1M | Buy |
142,504
+139,313
| +4,366% | +$20.3M | 1.72% | 7 |
|
|
2023
Q3 | $476K | Sell |
3,191
-87,656
| -96% | -$12.9M | 0.04% | 187 |
|
|
2023
Q2 | $12.2M | Buy |
90,847
+1,339
| +1% | +$196K | 0.89% | 23 |
|
|
2023
Q1 | $14.3M | Buy |
89,508
+33,924
| +61% | +$5.19M | 1.14% | 21 |
|
|
2022
Q4 | $8.98M | Sell |
55,584
-55,431
| -50% | -$8.5M | 0.79% | 22 |
|
|
2022
Q3 | $14.9M | Buy |
111,015
+259
| +0.2% | +$37.2K | 0.86% | 23 |
|
|
2022
Q2 | $17M | Sell |
110,756
-23,784
| -18% | -$3.63M | 0.98% | 19 |
|
|
2022
Q1 | $21.8M | Buy |
+134,540
| New | +$19.5M | 1.06% | 17 |
|
|
2021
Q4 | – | Sell |
-127,197
| Closed | -$13.7M | – | 1086 |
|
|
2021
Q3 | $13.7M | Sell |
127,197
-704
| -0.6% | -$80.4K | 0.72% | 27 |
|
|
2021
Q2 | $14.4M | Buy |
127,901
+3,360
| +3% | +$378K | 0.67% | 30 |
|
|
2021
Q1 | $13.5M | Buy |
124,541
+107,096
| +614% | +$11.5M | 0.69% | 28 |
|
|
2020
Q4 | $1.87M | Sell |
17,445
-105,030
| -86% | -$10.1M | 0.41% | 46 |
|
|
2020
Q3 | $10.7M | Buy |
122,475
+697
| +0.6% | +$65.6K | 0.69% | 27 |
|
|
2020
Q2 | $12M | Buy |
121,778
+21,867
| +22% | +$1.93M | 0.78% | 23 |
|
|
2020
Q1 | $7.61M | Buy |
99,911
+2,865
| +3% | +$244K | 0.59% | 33 |
|
|
2019
Q4 | $8.59M | Buy |
97,046
+26,516
| +38% | +$2.2M | 0.52% | 55 |
|
|
2019
Q3 | $5.34M | Buy |
70,530
+10,484
| +17% | +$719K | 0.36% | 80 |
|
|
2019
Q2 | $4.37M | Buy |
60,046
+12,154
| +25% | +$955K | 0.3% | 86 |
|
|
2019
Q1 | $3.86M | Buy |
47,892
+4,759
| +11% | +$389K | 0.3% | 87 |
|
|
2018
Q4 | $3.98M | Sell |
43,133
-6,358
| -13% | -$559K | 0.35% | 72 |
|
|
2018
Q3 | $4.68M | Sell |
49,491
-18,808
| -28% | -$1.78M | 0.35% | 80 |
|
|
2018
Q2 | $6.33M | Buy |
68,299
+13,519
| +25% | +$1.32M | 0.55% | 50 |
|
|
2018
Q1 | $5.18M | Sell |
54,780
-3,491
| -6% | -$383K | 0.48% | 51 |
|
|
2017
Q4 | $5.64M | Buy |
58,271
+2,405
| +4% | +$227K | 0.48% | 42 |
|
|
2017
Q3 | $4.96M | Sell |
55,866
-30,161
| -35% | -$2.3M | 0.54% | 46 |
|
|
2017
Q2 | $6.24M | Sell |
86,027
-31,496
| -27% | -$2.12M | 0.59% | 33 |
|
|
2017
Q1 | $7.66M | Buy |
117,523
+19,705
| +20% | +$1.24M | 0.69% | 30 |
|
|
2016
Q4 | $6.13M | Sell |
97,818
-68
| -0.1% | -$4.15K | 0.59% | 39 |
|
|
2016
Q3 | $6.17M | Buy |
97,886
+46,693
| +91% | +$3.02M | 0.52% | 32 |
|
|
2016
Q2 | $3.17M | Buy |
51,193
+2,453
| +5% | +$149K | 0.3% | 63 |
|
|
2016
Q1 | $2.78M | Buy |
48,740
+45,209
| +1,280% | +$2.52M | 0.26% | 84 |
|
|
2015
Q4 | $208K | Sell |
3,531
-20,802
| -85% | -$1.2M | 0.02% | 507 |
|
|
2015
Q3 | $1.32M | Sell |
24,333
-21,484
| -47% | -$1.4M | 0.13% | 172 |
|
|
2015
Q2 | $3.08M | Buy |
45,817
+2,702
| +6% | +$176K | 0.31% | 69 |
|
|
2015
Q1 | $2.52M | Hold |
43,115
| – | – | 0.27% | 98 |
|
|
2014
Q4 | $2.82M | Buy |
+43,115
| New | +$2.72M | 0.36% | 86 |
|
|
2014
Q2 | – | Sell |
-64,815
| Closed | -$3.33M | – | 336 |
|
|
2014
Q1 | $3.33M | Hold |
64,815
| – | – | 0.55% | 59 |
|
|
2013
Q4 | $3.42M | Buy |
+64,815
| New | +$3.19M | 0.58% | 52 |
|
Other funds holding ABBV
VCM
VPM
Meeder Asset Management's ABBV Position: Q1 2026 in Review
Meeder Asset Management increased its AbbVie (ABBV) stake by 14% in Q1 2026, buying an estimated $2.13M and bringing the position to 79,562 shares worth $17.3M. The position accounts for 0.99% of the portfolio, ranked #22.
Meeder Asset Management first reported a position in ABBV in Q4 2013 and has held it in 47 quarters since. The position peaked at $36M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Meeder Asset Management held 79,562 shares of AbbVie worth $17.3M as of Q1 2026.
- Meeder Asset Management bought 9,584 AbbVie shares in Q1 2026, an estimated $2.13M.
- AbbVie made up 0.99% of Meeder Asset Management's portfolio in Q1 2026, its #22 holding.
- Meeder Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 47 quarters since.
- Meeder Asset Management's AbbVie position peaked at $36M in Q3 2024.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.